.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
US Department of Justice
Express Scripts
McKesson
Dow
Covington
Cerilliant
Cipla
Deloitte

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,500,444

« Back to Dashboard

Which drugs does patent 7,500,444 protect, and when does it expire?


Patent 7,500,444 protects ADVAIR HFA, FLOVENT HFA, and VENTOLIN HFA, and is included in three NDAs.

Protection for ADVAIR HFA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 7,500,444

Title:Actuation indicator for a dispensing device
Abstract:An actuation indicator that includes a drum sub-assembly, which includes a rotatable actuation indicator wheel, a rocking, ratchet pawl for rotating the indicator wheel in a set direction and a rocking mechanism for the pawl driven by a slipping clutch arrangement, is described. The slipping clutch arrangement includes a slipping clutch spring engaged at one end to a pinion of a rack and pinion assembly and at a second end to the ratchet pawl.
Inventor(s): Bonney; Stanley George (Ware, GB), Brand; Peter John (Ware, GB), Godfrey; James William (Ware, GB), Rand; Paul Kenneth (Ware, GB)
Assignee: Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:10/518,421
Patent Claim Types:
see list of patent claims
Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Glaxo Grp LtdADVAIR HFAfluticasone propionate; salmeterol xinafoateAEROSOL, METERED;INHALATION021254-001Jun 8, 2006RXYesYes► Subscribe► SubscribeY► Subscribe
Glaxo Grp LtdADVAIR HFAfluticasone propionate; salmeterol xinafoateAEROSOL, METERED;INHALATION021254-002Jun 8, 2006RXYesYes► Subscribe► SubscribeY► Subscribe
Glaxo Grp LtdADVAIR HFAfluticasone propionate; salmeterol xinafoateAEROSOL, METERED;INHALATION021254-003Jun 8, 2006RXYesYes► Subscribe► SubscribeY► Subscribe
Glaxo Grp LtdFLOVENT HFAfluticasone propionateAEROSOL, METERED;INHALATION021433-003May 14, 2004RXYesYes► Subscribe► SubscribeY► Subscribe
Glaxo Grp LtdFLOVENT HFAfluticasone propionateAEROSOL, METERED;INHALATION021433-002May 14, 2004RXYesYes► Subscribe► SubscribeY► Subscribe
Glaxo Grp LtdFLOVENT HFAfluticasone propionateAEROSOL, METERED;INHALATION021433-001May 14, 2004RXYesYes► Subscribe► SubscribeY► Subscribe
GlaxosmithklineVENTOLIN HFAalbuterol sulfateAEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,500,444

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0214360.0Jun 21, 2002
United Kingdom0311191.1May 15, 2003
PCT Information
PCT FiledJune 19, 2003PCT Application Number:PCT/EP03/06466
PCT Publication Date:December 31, 2003PCT Publication Number: WO04/001664

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Covington
McKinsey
Citi
Colorcon
Deloitte
Cipla
Queensland Health
Healthtrust
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot